These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2341804)

  • 1. Studies on the metabolism of apolipoprotein B in hypertriglyceridemic subjects using simultaneous administration of tritiated leucine and radioiodinated very low density lipoprotein.
    Beltz WF; Kesäniemi YA; Miller NH; Fisher WR; Grundy SM; Zech LA
    J Lipid Res; 1990 Mar; 31(3):361-74. PubMed ID: 2341804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic pathways of apolipoprotein B in heterozygous familial hypercholesterolemia: studies with a [3H]leucine tracer.
    Fisher WR; Zech LA; Kilgore LL; Stacpoole PW
    J Lipid Res; 1991 Nov; 32(11):1823-36. PubMed ID: 1770302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism.
    Packard CJ; Gaw A; Demant T; Shepherd J
    J Lipid Res; 1995 Jan; 36(1):172-87. PubMed ID: 7706942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men.
    Millar JS; Lichtenstein AH; Cuchel M; Dolnikowski GG; Hachey DL; Cohn JS; Schaefer EJ
    J Lipid Res; 1995 Jun; 36(6):1155-67. PubMed ID: 7665994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of apolipoprotein B in subjects with hypertriglyceridemia and polydisperse LDL.
    Fisher WR; Zech LA; Bardalaye P; Warmke G; Berman M
    J Lipid Res; 1980 Aug; 21(6):760-74. PubMed ID: 7419987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model development to describe the heterogeneous kinetics of apolipoprotein B and triglyceride in hypertriglyceridemic subjects.
    Barrett PH; Baker N; Nestel PJ
    J Lipid Res; 1991 May; 32(5):743-62. PubMed ID: 2072038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins.
    Gaw A; Packard CJ; Lindsay GM; Griffin BA; Caslake MJ; Lorimer AR; Shepherd J
    J Lipid Res; 1995 Jan; 36(1):158-71. PubMed ID: 7706941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
    Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U
    J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity.
    Pont F; Duvillard L; Florentin E; Gambert P; Vergès B
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1726-32. PubMed ID: 12377756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins.
    Beltz WF; Kesäniemi YA; Howard BV; Grundy SM
    J Clin Invest; 1985 Aug; 76(2):575-85. PubMed ID: 4031063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions.
    Packard CJ; Demant T; Stewart JP; Bedford D; Caslake MJ; Schwertfeger G; Bedynek A; Shepherd J; Seidel D
    J Lipid Res; 2000 Feb; 41(2):305-18. PubMed ID: 10681415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic mechanisms of action of lovastatin in nephrotic syndrome.
    Aguilar-Salinas CA; Barrett PH; Kelber J; Delmez J; Schonfeld G
    J Lipid Res; 1995 Jan; 36(1):188-99. PubMed ID: 7706943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 1,2-cyclohexanedione modification on the metabolism of very low density lipoprotein apolipoprotein B: potential role of receptors in intermediate density lipoprotein catabolism.
    Packard CJ; Boag DE; Clegg R; Bedford D; Shepherd J
    J Lipid Res; 1985 Sep; 26(9):1058-67. PubMed ID: 4067428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
    Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects.
    Berman M; Hall M; Levy RI; Eisenberg S; Bilheimer DW; Phair RD; Goebel RH
    J Lipid Res; 1978 Jan; 19(1):38-56. PubMed ID: 202659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.
    Arad Y; Ramakrishnan R; Ginsberg HN
    J Lipid Res; 1990 Apr; 31(4):567-82. PubMed ID: 2351867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overproduction of a kinetic subclass of VLDL-apoB, and direct catabolism of VLDL-apoB in human endogenous hypertriglyceridemia: an analytical model solution of tracer data.
    Eaton RP; Allen RC; Schade DS
    J Lipid Res; 1983 Oct; 24(10):1291-303. PubMed ID: 6644179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
    Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of apoB-100 in lipoproteins separated by density gradient ultracentrifugation in normal and Watanabe heritable hyperlipidemic rabbits.
    Shames DM; Yamada N; Havel RJ
    J Lipid Res; 1990 May; 31(5):753-62. PubMed ID: 2380627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.